ElendiLabs — Regulatory consultancy platform connecting medical device and pharmaceutical manufacturers with verified experts worldwide
All regulatory hubs
Regulatory hub

Overview of the FDA Philippines Medical Device Regulatory Framework

An overview of the Philippine FDA's Center for Device Regulation, Radiation Health, and Research (CDRRHR) and its role in licensing and product registration.

Overview

Summary of this regulator or jurisdiction and how it relates to market access.

Official regulator site

Food and Drug Administration (FDA) Philippines - CDRRHR

The Center for Device Regulation, Radiation Health, and Research (CDRRHR) is the specialized branch of the Philippine FDA responsible for the regulation of medical devices, ensuring they meet national standards for safety, quality, and efficacy.

1. Regulatory Role

Under Republic Act No. 9711, the FDA mandates that all medical device establishments must obtain a License to Operate (LTO) and register their products before they can be legally distributed in the country.

2. Licensing of Establishments (LTO)

The provided eServices portal facilitates the application for the LTO. This license is required for:

  • Manufacturers
  • Traders
  • Distributors (Importers, Exporters, and Wholesalers)

3. Product Classification and Registration

In alignment with ASEAN Harmonized Templates, the Philippines classifies devices based on risk:

  • Class A (Low Risk): Requires a Certificate of Medical Device Notification (CMDN).
  • Class B (Low-Moderate Risk): Requires a Certificate of Medical Device Registration (CMDR).
  • Class C (Moderate-High Risk): Requires a CMDR.
  • Class D (High Risk): Requires a CMDR.

4. Digital Transformation (eServices)

The FDA has transitioned to an online platform for LTO applications to streamline the process, reduce manual paperwork, and enhance transparency in the regulatory pipeline.

Articles & guides

Insight articles mapped to this region on ElendiLabs.

Post Market Surveillance

June 1, 2025

Philippines Medical Device Post-Market Surveillance: Vigilance and ASEAN Alignment

Philippines FDA's Post-Market Surveillance (PMS) is transitioning towards mandatory adoption of ASEAN Vigilance guidelines (AMDD Annex 5). PMS requires local dealers to maintain traceability records, implement a complaint handling system, and manage Adverse Event (AE) reporting and Field Safety Corrective Actions (FSCA).

Read article

Medical Advertisements

May 1, 2025

Philippines Medical Device Advertising: Compliance with Consumer Act and ASC Review

Medical device advertising in the Philippines is governed by the Consumer Act (RA 7394) and requires screening by the Ad Standards Council (ASC) to ensure honesty and accuracy. Sales promotions require a separate Sales Promo Permit from the FDA.

Read article

Registration

April 1, 2025

Philippines Medical Device Labeling: Compliance with ASEAN MDD and Local Requirements

Medical device labeling in the Philippines is guided by the ASEAN MDD and is subject to FDA review. Labels must be in English and/or Filipino, contain comprehensive product and use details, and reflect the device's market authorization status (CMDN or CMDR).

Read article

Registration

March 1, 2025

Philippines SaMD Registration: Regulatory Framework and Technical Standards

The Philippines FDA explicitly defines Software as a Medical Device (SaMD) under AO 2018-0002, requiring risk-based registration (CMDN/CMDR). Technical documentation must comply with international standards (e.g., IEC 62304), and data privacy laws (RA 10173) must also be observed.

Read article

Registration

February 1, 2025

Philippines Medical Device Grouping: Rules for Consolidating Registration Applications

The Philippines FDA uses specific, strict rules for grouping multiple medical devices under a single registration (CMDN/CMDR) to reduce costs and streamline the process. Grouping is permitted for accessories, systems, devices with common intended use/manufacturing processes, and devices with varying materials or designs.

Read article

Registration

January 3, 2025

Philippines Medical Device Classification: Aligning with ASEAN MDD Risk Rules

The Philippines FDA uses a risk-based classification system (Class A to D) aligned with the ASEAN Medical Device Directive (MDD). Classification determines the required market authorization: CMDN (Notification) for Class A and CMDR (Registration) for Classes B, C, and D.

Read article

Registration

November 26, 2024

Philippines IVD Device Registration: Transitioning to AMDD Classification and CIVDR/CIVDN

The Philippines FDA (CDRRHR) is transitioning IVD registration to the AMDD risk classification. Registration requires a Certificate of IVD Notification (CIVDN) or Registration (CIVDR), in-country testing for high-risk classes, CSDT documentation, and authentication of legal documents by the Philippine Consulate.

Read article

Registration

October 26, 2024

Philippines Medical Device Registration: CMDN, CMDR, and ASEAN Harmonization

The Philippines FDA (CDRRHR) uses ASEAN-harmonized Class A-D classification and two main approval routes: Certificate of Medical Device Notification (CMDN) for Class A and Certificate of Medical Device Registration (CMDR) for Classes B, C, and D. Home/Reference country approval is generally required.

Read article